Skip to Content

Kyzatrex FDA Approval Status

FDA Approved: No
Brand name: Kyzatrex
Generic name: testosterone undecanoate
Company: Marius Pharmaceuticals
Treatment for: Hypogonadism, Male

Kyzatrex (testosterone undecanoate) is a novel, soft gelatin capsule testosterone formulation in development for the treatment of primary and secondary hypogonadism in adult men.

Development Timeline for Kyzatrex

DateArticle
Jan  5, 2021Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Kyzatrex Next-generation Oral Testosterone Replacement Therapy in Male Patients with Hypogonadism

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.